, IV/36.997/F3 Aseprofar and Fedifar (complaint) , IV/37.121/F3 Spain Pharma (complaint) , IV/ 37.138/F3 BAI (complaint) and IV/37.380/F3 EAEPC (complaint) , in that it sets the amount of the fine imposed on the applicant; second, an application for a reduction in the amount of the find; and, third, an application for repayment to the applicant of the amounts unlawfully received.
Operative part of the judgment
The Court: .756 -Sodium Gluconate) in so far as it pertains to the applicant, or at least to the extent that it finds the applicant was party to an infringement after 4 October 1994, and for annulment of Article 3 of that decision in so far as it pertains to the applicant or, in the alternative, annulment or reduction of the fine imposed on it by the decision.
